Live Oak Private Wealth’s abrdn Life Sciences Investors HQL Stock Holding History
Bought
Maintained
Sold
Other funds holding HQL
SCM
PCM
NIM
FHA
RCM
Live Oak Private Wealth's HQL Position: Q1 2026 in Review
Live Oak Private Wealth held its abrdn Life Sciences Investors (HQL) position steady in Q1 2026 at 13,223 shares worth $215K. The position accounts for 0.03% of the portfolio, ranked #188.
Live Oak Private Wealth first reported a position in HQL in Q2 2020 and has held it in 24 quarters since. The position peaked at $284K in Q2 2021. 86 funds tracked by Wall St. Rank hold HQL as of Q1 2026.
- Live Oak Private Wealth held 13,223 shares of abrdn Life Sciences Investors worth $215K as of Q1 2026.
- Live Oak Private Wealth left its abrdn Life Sciences Investors share count unchanged in Q1 2026.
- abrdn Life Sciences Investors made up 0.03% of Live Oak Private Wealth's portfolio in Q1 2026, its #188 holding.
- Live Oak Private Wealth first reported a position in abrdn Life Sciences Investors in Q2 2020 and has held it in 24 quarters since.
- Live Oak Private Wealth's abrdn Life Sciences Investors position peaked at $284K in Q2 2021.
- 86 funds tracked by Wall St. Rank held abrdn Life Sciences Investors as of Q1 2026.
Based on Live Oak Private Wealth's 13F filing for Q1 2026, filed 20 Apr 2026.